Diabetic Nephropathy: Clinical Trials

3 trials for Diabetic Nephropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Terminated 3

Follow Diabetic Nephropathy: new trials by email Literature Review of Diabetic Nephropathy trials Research Report on Diabetic Nephropathy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Aliskiren, Valsartan - Proteinuric Kidney Disease, Diabetic Nephropathy
Phase 4TerminatedColumbia University462009-09-012014-05-15
Effect of Sulodexide in Overt Diabetic Nephropathy
Sulodexide, Placebo - Diabetic Nephropathy
Phase 4TerminatedKeryx Biopharmaceuticals9682005-08-012021-03-19
A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
valsartan - Hypertension, Diabetic Nephropathy
Phase 4TerminatedNovartis Pharmaceuticals812004-01-012008-12-17

Narrower conditions

Diabetic Nephropathies (3)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Glomerulonephritis, IGA (1)  ·  Glomerulonephritis, Membranous (1)  ·  Glomerulosclerosis, Focal Segmental (1)  ·  Hypertension (1)  ·  Proteinuria (1)

Broader conditions

Diabetes Complications (3)  ·  Endocrine System Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Diabetes Mellitus (2)  ·  Glucose Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Autoimmune Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Glomerulonephritis (1)

Interventions

Valsartan (2)  ·  aliskiren (1)  ·  glucuronyl glucosamine glycan sulfate (1)

Sponsors

Columbia University (1)  ·  Keryx Biopharmaceuticals (1)  ·  Novartis Pharmaceuticals (1)

Countries

United States (2)  ·  Australia (1)  ·  Netherlands (1)  ·  Switzerland (1)

Top investigators

Edmund J Lewis, MD (1)  ·  Itamar Raz, M.D. (1)  ·  Pietro Canetta, MD (1)  ·  Robert C Atkins, M.D. (1)

Results publications

PMID 22995802, PMID 28341782